Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumab
Crossref DOI link: https://doi.org/10.1007/s00280-016-2980-3
Published Online: 2016-02-10
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Agrawal, Shruti
Waxman, Ian
Lambert, Alexandre
Roy, Amit
Darbenzio, Raymond
Funding for this research was provided by:
Bristol-Myers Squibb
Text and Data Mining valid from 2016-02-10